Amino acid PET imaging improves diagnosis of pediatric glioma

06/11/2013 | MolecularImaging.net

In pediatric patients with suspected neoplastic tissue, PET imaging with the amino acid tracer 18F-FET showed 87% accuracy in differentiating between lesions that were tumors and those that were non-neoplastic, according to a study presented at the SNMMI Annual Meeting. Repeated PET imaging showed 94% accuracy in ruling out tumor progression or residual tumor in a small subgroup, researchers said. "Our findings suggest that in children and young adults, FET PET can add relevant additional clinical information for treatment planning and monitoring when MRI is equivocal," said Dr. Veronika Dunkl of the Institute of Neuroscience and Medicine at Julich Research Centre in Julich, Germany, and colleagues.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA